Category Archives: What We Do

Luce Report 2018: Challenges in Lung Cancer Clinical Trials

Welcome to the 3rd edition of the LuCE Report. This report is an annual initiative led by lung cancer patient organisations, with the purpose of raising awareness about the biggest challenges that patients across Europe face. This 3rd report focusses on clinical trials and welcomes the progress made in lung cancer treatment in recent years. However, it also seeks to […]

Read More

28th November: Current challenges in clinical trials

Lung Cancer Europe will hold an event on 28th November at the EU Parliament to highlight the current challenges in clinical trials across Europe Within the occasion of this event, the 3rd edition of the LuCE report, which highlights some of the challenges still faced regarding research, will be presented. For the third consecutive year, LuCE will hold an event at […]

Read More

LuCE at ASCO 2018 – Lung cancer screening

LuCE members Walce Onlus & Fundacion Mas Que Ideas attended the American Society of Clinical Oncology (ASCO) Annual Meeting. They talked with MD Paolo Bironzo about the topics on immunotherapy in lung cancer presented at ASCO 2018. Check out here the interview https://t.co/vg13smrVYS

Read More